Abstract
The present invention provides new coumestans compounds and processes for the preparation of coumestans, pharmaceutical compositions having a coumestan as an active pharmaceutical ingredient, and methods of utilizing coumestans as selective estrogen receptor modulators (SERMs) for treating estrogen dependent diseases such as breast cancer.
| Original language | American English |
|---|---|
| Patent number | 20150336977 |
| State | Published - 26 Nov 2015 |